Martingale Asset Management L P Castle Biosciences Inc Transaction History

Martingale Asset Management L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$39.06 - $67.58 $529,458 - $916,046	-13,555 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$60.13 - $77.6 $496,072 - $640,200	8,250 Added 155.51%	13,555 $901,000
Q2 2021 Aug 13, 2021	SELL	$50.07 - $76.78 $5,007 - $7,678	-100 Reduced 1.85%	5,305 $389,000
Q1 2021 May 13, 2021	SELL	$58.92 - $97.33 $5,892 - $9,733	-100 Reduced 1.82%	5,405 $370,000
Q4 2020 Feb 10, 2021	SELL	$43.6 - $73.05 $937,400 - $1.57 Million	-21,500 Reduced 79.61%	5,505 $369,000
Q3 2020 Nov 12, 2020	BUY	$38.47 - $52.03 $1.04 Million - $1.41 Million	27,005 New	27,005 $1.39 Million

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $701M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.